Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allegro: Steroid Free or CNI Minimization in Kidney Transplant
NCT01560572Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Apr 2011
- Primary completion
- Apr 2015
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus in kidney transplantation (3 arms), sponsored by University Medical Center Groningen. Primary endpoint: Renal Function (Creatinine, Clearance, CKD-EPI) at 24 months. Started Apr 2011; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01560572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01560572.